​

Vicore Pharma Holding AB Stock (NASDAQ:VCRE)


RevenueFinancialsChart

Previous Close

$8.74

52W Range

$8.39 - $17.80

50D Avg

$11.09

200D Avg

$11.47

Market Cap

$2.44B

Avg Vol (3M)

$15.99K

Beta

0.15

Div Yield

-

VCRE Company Profile


Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

SE

Employees

37

IPO Date

Jul 02, 2026

Website

VCRE Performance


VCRE Financial Summary


Dec 25
Revenue$3.82M
Operating Income$-454.44M
Net Income$-477.47M
EBITDA$-477.41M
Basic EPS$-19.90
Diluted EPS$-19.90

Fiscal year ends in Dec 25 | Currency in SEK

Peer Comparison


TickerCompany
LQDALiquidia Corporation
AVLNAvalyn Pharma Inc. Common Stock